What For?

Diets rich in polyphenols, the natural plant-based phytochemicals found in healthy foods, have been linked with lower risks of chronic illnesses such as dementia, high cholesterol, arthritis, heart disease, skin aging and macular degeneration [Denny, Elments, Karppi, Rezai-Zadeh, Porrini]. Well-conducted population studies have also linked their regular intake with lower risks of many cancers including breast [Hu], pancreatic [Banim], oesophageal [Sun], ovarian [Wu, Tung], prostate [Giovannucci, Chaoyang, Joseph], and skin cancer [Heinen].

The anti-cancer effects of polyphenols, however, do not stop after a diagnosis of cancer. Breast cancer survivors eating polyphenol-rich fruit, vegetables, soy and green tea were found to have lower relapse rates [Pierce, Buck, Boyapati, Ogunleye]. Individuals with skin cancer, who had a high intake of leafy green vegetables and broccoli, had lower rates of new cancer formation [Heinen]. A healthy lifestyle including a polyphenol rich diet has been linked to a slower rate of PSA progression among men with painless prostate cancer [Ornish].

Although polyphenol-rich supplements are showing some promise, it is clear that not all polyphenols have anti-cancer effects, and those which do, are likely to have different benefits in different combinations amongst different individuals [Parada, Greenhall, Moysich, Porrini]. The largest and scientifically robust evaluation was the Pomi-T study. This double blind randomised controlled trial (RCT) involved 200 men with slowly progressing prostate cancer. There was a
63% difference in the rate of rise of PSA and a significant number of men stayed on active surveillance on the food supplement arm [Thomas ASCO 2013].


Albanes D, et al. The effect of Vit E and beta carotene supplementation and lung cancer incidence in the vit A & E cancer prevention trial in male smokers (1994) NEJM 1994, 330: 11029-35. Angie MA. Accurate Use of Prostate-specific Antigen in Determining Risk of Prostate Cancer. Journal for Nurse Practitioners. 2010; 6(3):177-184.

Banim PJ, et al. Dietary antioxidants and the aetiology of pancreatic cancer (2012). Gut doi:10.1136/gutjnl-2011-301908.

Bourke L, et al. (2013) Endocrine therapy in prostate Cancer: time for reappraisal of risks, benefits and cost effectiveness? British Journal of Cancer 108,9-13 doi 10.1038/bjc2012.523.

Bauer CM, et al. Prevalence and correlates of vitamin and supplement usage among men with a family history of prostate cancer. Integr Cancer Ther. 2012 11(2):83-9.

Barber NJ, et al. Lycopene inhibits DNA synthesis in prostate cells in vitro and is associated with a reduced PSA velocity in a phase II clinical study. Prostate Cancer Prostatic Dis ( 2006).9(4): 407-13.

Bent S, Kane C, Shinohara K, Neuhaus J, Hudes ES, Goldberg H, Avinset A. Saw Palmetto for Benign Prostatic Hyperplasia (2006). N Engl J Med; 354(6): 557- 566. (doi: 10.1056/NEJMoa053085).

Brasky TM et al (2011). Specialty supplements and prostate cancer risk in the VITamins and Lifestyle (VITAL) cohort. Nutr Cancer. 63(4):573-82 (doi: 10.1080/01635581.2011.553022).

Buck K, et al Serum enterolactone and prognosisi of postmenopausal breast cancer. JCO 2011 vol. 29 no. 28 pp.3730-3738 (doi 10.1200/JCO.2011.34.6478)

Chan JM, Gann PH and Giovannucci EL. Role of diet in prostate cancer development and progression (2005). JCO, 23(32): 8152. (doi: 328152-8160)

Boyapati SM, Shu XO, Ruan ZX, Dai Q, Cai Q, Gao YT, Zheng W. Soyfood intake and breast cancer survival: a follow up of the Shanghai Breast Cancer Study. Breast Cancer Res Treat. 2005;92:11–7.

Cancernet.co.uk/nutritional-tests.htm. Rationale, evidence and facilities for micronutrient testing. Accessed August 2013-05-01 Carducci MA, Paller CJ, Wozniak P, Sieber P, Greengold R, Stockton B, Hertzman B, roper R, Liker H, Ye X. A phase II study of pomegranate extract for men with rising PSA (2011). JCO, 29: 7, 11.

American Cancer Society: Cancer treatment and survivourship Facts and figures 2012-13. Atlanta.

Blot WJ, et al. Nutritional interevention trials in Linxian China: Supplementation with specific vitamin/mineral combinations, J Natl Cancer inst 1993;85: 1483-91.

Chaoyang L et al Serum alpha-carotene concentrations and the risk of death amoung US adults (2011) Arch Intern Med 171(6); 507-15 doi:10.1001/archinternmed.2010.440.

Choi C, Liao Y; Wu S; Leu Y; Shen Y. The structure of pomegranate has no hormonal component (2006). Mass Spec Food Chem, 96; 4, 562.

Chuang S. A U-shaped relationship between plasma folate and pancreatic cancer risk in the EPIC and Nutrition study (2011). EJC 47, 1808-16 doi:10.1016/j.ejca.2011.02.007.

Clark PE, et al Phase I-II prospective dose-escalating trial of lycopene in patients with biochemical relapse of prostate cancer after definitive local therapy. Urology 67 (6): 1257-61, 2006.

Denny A, Buttriss J. Plant foods and health: focus on plant bioactives. 2007. EU Information Resource (EuroFIR) Consortium. Contract FOOD-CT- 2005-513944

Dorai T, gehani N, Katz A. Therapeutic potential of curcumin in human prostate cancer. Curcumin inhibits tyrosine kinase activity of the Eipdermalgrowth factor receptor. Mol Urol. 2000; 4(1): 1-6

Ebbing M et al (2009) Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B12 JAMA. 2009;302(19):2119-2126.

Elmets CA, Singh D, Tubesing K, et al. Cutaneous photoprotection from ultraviolet injury by green tea polyphenols. Journal of the American Academy of Dermatology 2001; 44(3):425–432.

Figueiredo JC et al (2009). Folic Acid and Risk of Prostate Cancer: Results From a Randomized Clinical Trial.J. Natl. Cancer Inst. 101(6): 432-435. (doi: 10.1093/jnci/djp019)

Gasper AV et al The dietary isothiocyanate sulforaphane modulates gene expression and alternative gene splicing in a model of prostate cancer. Molecular Cancer 2010, 9:189

Gasper AV et al (2005) Glutathione S-transferase M1 polymorphism and metabolism of sulforaphane from standard and high-glucosinolate broccoli. Am J Clin Nutr 82: 1283–1291.

Giovannucci E, Rimm EB, Liu Y, Stampfer MJ, Willett WC. (2002) A prospective study of tomato products, lycopene, and prostate cancer risk. Journal of the National Cancer Institute, 94: 391-398.

Greenwald P, Milner JA, Anderson DE, McDonald SS. Micronutrients in cancer prevention (2002) Cancer metastasis Rev 21 (3-4): 217-30.

Handler N, Jaeger W, Puschacher H, Leissser K, Erker T. Synthesis of noval curcumin analogues and their evaluation as selective cyclooxygenase-1 inhibitors. Chem Pharm Bull. 2007 55(1): 64-71

Heinonen O, et al Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. Journal of the Nat Can Institute 1998; 90: 440-9

Hercberg S et al The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med. 2004;164(21):2335-42.

Hellhammer D et al. Changes in saliva testosterone after psychological stimulation in Men. Psychoneuroendocrinology (1985) Vol.10, p77-81.(doi:10.1016/0306-4530(85)

Heinen MM, Hughes MC, Ibiebele TI, Marks GC, Green CM, van der Pols. Intake of antioxidant nutrients and the risk of skin cancer (2007) EJC 43; (18) pp 2707-16.

Hu F, et al (2012). Carotenoids and breast Cancer risk: a meta-analysis and meta-regression. Breat Cancer Res Treat 131(1): 239-53, doi 10.1007/s10549-011-1723-8.epub2011

Iqbal M, Sharma SD, Okazaki Y, Okada S (2003) Dietary supplementation of curcurmin enhances antioxidant phase II metabolosing enzymes in mice. Pharmacol Toxicol; 92 (1); pp33-8.

Joseph MA, et al Cruciferous vegetables, genetic polymorphisms and prostate cancer risk. Nutr Cancer. 2004;50(2):206-213.

Jatoi A et al. A phase II trial of green tea in patients with metastatic prostate carcinoma. Cancer. 2003;97(6):1442.

Kakarla M, et al (2010) targeting breast stem cells with the preventive compounds curcumin and piperine Breast Cancer Res treatments 122(3):777-785.

Karppi J,Laukkanen JA, Sivenius J, Ronkainen K, Kurl S. Serum lycopene decreases the risk of stroke in men (2012) Neurology, 79(15) 134-47 (doi:10.1212/WNL.0b013e31826e26a6)

Khan N and Mukhtar H. Pomegranate inhibits growth of primary lung tumors in mice. Cancer Res 2007;67:3475-82. (doi:10.1358/dof.2007.032.06.1097137).

Klein EA, et al Vitamin E and the risk of Prostate cancer. The selenium and vitamin E cancer prevention Trial (SELECT)(2011). JAMA 306(14) 1549-56 doi:10.1001/jama.2011.1437.

Klotz L (2012) Active surveillance for favourable risk Prostate Cancer: Background , patient Selection, triggers for intervention and outcome. Curr Urol Rep 13:153-59.

Lansky EP et al Possible synergistic prostate cancer suppression by anatomically discrete megranate fractions. Invest New Drugs. 2005;23:11–20.

Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willet WC, Giovannucci EL. Zinc supplementation and the risks of prostate cancer. J Natl cancer Inst (2003), 95: 1004-1007

Liao J, yang GY, Park ES (2004). Inhibition of lung carcinogenesis and effects on angiogenesis and apoptosis in mice given green tea. Nutr Cancer, 48 (1), pp.44-53

Malik A, et al. Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA. 2005;102:14813–14818.

McLarty J Tea Polyphenols – biochemical mode of action (2009). Cancer Prev Res: 1940-6207.CAPR-08-0167.

Meyer F, et al Antioxidant vitamin and mineral supplementation and prostate cancer prevention in the SU.VI.MAX trail. National Library of Medicine, Int J Cancer. 2005; 116 (2): 182-6.

Ogunleye AA, Xue F, Michels KB. Green tea and breast cancer risk of recurrence: A meta-analysis.(2010) Breast Cancer Res &Treat; 119(2):477.

Omenn GS, et al., (1996) Risk factors for lung cancer and for intervention effects in CARET, the beta-carotene in retinol efficacy trial. Journal of the National Cancer Institute, 88: p. 1550-1559.

Paller CJ, et al. A RCT (phase II) study of pomegranate extract for men with rising PSA following initial therapy for localized prostate cancer. (2013) Prostate Cancer & Prostate Disease 16, 50-55.

Pantuck AJ, Phase II study of pomegranate juice for men with rising PSA following surgery or radiation for prostate cancer. J Urol. 2005;173:225–226.

Parada j and Aguilera JM. Food combinations and microstructure affects the bioavailability of several nutrients. J Food Sci. (2007);72:21-23.

Porrini M and Riso P. Factors influencing the bioavailability of antioxidants in foods: a critical appraisal. Nutr Metab Cardiovas. 2008:80(4):353-61.

Pierce et al. (2007). Influence of a Diet Very High in Vegetables, Fruit, and Fibre and Low in Fat on Prognosis Following Treatment for Breast Cancer: The “WHEL” RCT.” JAMA 298(3): 289-298.

Pisters KM, et al Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol. 2001;19(6):1830.

Rezai-Zadeh K, et al Green tea modulates amyloid precursor protein cleavage and reduces cerebral amyloid in Alzheimer transgenic mice (2005). J Neurosci 25 (38): 8807-14.

Posadzki P, et al Dietary Supplements and prostate cancer: a systematic review of double-blind, placebo-controlled randomised clinical trials. (2103) aturitas S0378-5122(13)00079-0

Rettig MB, et al. Pomegranate extract inhibits androgen independent prostate cancer growth through a nuclear factor-κβ-dependent mechanism. Mol Cancer Ther. 2008;7:2662–2671

Reichman ME,, et al. Serum vit A and subsequent development of prostate cancer in the National Health and Nutrition Exam Survey Epidemiologic Follow-up Study. Cancer Res 1990; 50:2311–15

Rock CL, et al Carotenoids and Recurrence-Free Survival in Women With a History of Breast Cancer (2005) J Clin Oncol; 23(27):6631-8.

Schröder FH, et al Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA: effectiveness of a dietary supplement. Eur Urol 2005 48(6):922-30.

Shah BH, et al (1999). Inhibitory effect of curcumin, on platelet-activating factor through inhibition of thromboxane formation and Ca2+ signaling. Biochem Pharmacol., 58(7): 1167–1172.

Schenk JM et al. Serum Retinol and Prostate Cancer Risk: a Case-Control Study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epi Bio Prev. 2009 18(4): 1227–31

Somasundaram S, Edmund NA, Moore DT, Small GW, Shi YY, Orlowski RZ. Curcumin inhibits chemotherapy-induced apoptosis in models of cancer. Cancer Res. 2002;62(13):3868-75.

Sonn GA, Aronson W, Litwin MS. Impact of diet on prostate cancer: A review. Prostate Cancer Prostatic Dis. 2005;8:304–10

Shanafelt TD, Phase I Trial of daily oral polyphenon E (green tea extract) in patients with Asymptomatic stage 0-II Chronic Lymphatic Leakaemia. (2009). J Clin Oncol; 27(23): 3808–3814.

Steward W and Gescher AJ Curcumin in cancer management: Recent results of analogue design, clinical studies and desirable future research Molecular Nutrition & Food Research, 52 (9) 1005-9.

Sun CL, Yuan JM, Koh WP, Lee HP, Yu MC, Green tea and cancer risk: The Singapore Chinese Health Study (2007). Carcinogenesis; 28(10):2143-48 (doi: 10.1093/carcin/bgm171).

Thomas R et al A randomised double-blind phase II study of lifestyle counselling and salicylate compounds in patients with progressive prostate cancer (2009) Nut & Food Science, 39(3):295–05.

Tsang C, et al. Intake of pomegranate influences urinary glucocorticoids, BP and homeostasis model assessment of insulin resistance in human volunteers. (2102) J Nut Sci, 1, pp 1-9

Tung K, et al. Association of dietary vitamin A, carotenoids and other antioxidants with the risk of ovarian cancer (2005) Cancer Epidemiol Biomarkers Prev; 14;669

Uzzo RG, Brown et al Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer. BJU Int. 2004. 93(7):955-60.

Wang L, et al. Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells. Integr Biol (Camb) 2011;3:742–754

Wu AH and Yu MCl. Tea, hormone-related cancers and endogenous hormone levels (2006). Molecular Nutrition & Food Res; 50(2):160-169 (DOI: 10.1002/mnfr.200500142).

Yang CS, Maliakal P, Meng X. Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol. 2002;42:25-54.

Zhang HN, Yu CX, Chen WW, Young CY (2007), Curcumin down regulates gene NKX3.1 in prostate cancer cell lines (LNcaP) (2007). Acta Pharmacologica